Christopher Madrid
For individuals managing complex peptide research or dosing protocols who prioritize data privacy and precise reconstitution calculations.
Snapshot
Who is Christopher Madrid?
Providing individuals with private, precision tools for tracking and managing personal peptide protocols and inventory.
Target audience
Portfolio
Last updated
PeptideJournal
v1.1.7
9mo ago
Publisher DNA
What defines Christopher Madrid?
Publisher DNA
Primary focus
Personal peptide tracking and inventory management
Scale
indie
Target audience
Individuals managing complex peptide research or dosing protocols who prioritize data privacy and precise reconstitution calculations.
Signature Patterns
- •Privacy-centric architecture with 100% local device storage and no external syncing.
- •Specialized focus on reconstitution simulation and multi-peptide blend calculations.
- •Monetization via a paid-upfront model rather than recurring subscriptions.
- •High-frequency update cadence to refine technical tracking and inventory features.
Portfolio momentum
Maintained an active development cycle with 8 updates in the last 6 months for its single flagship title.
Portfolio
What does Christopher Madrid ship?
Apps
1 app analysed
Precision-focused calculator tools drive daily reliance
- The integrated calculator and calendar tools simplify complex dosing schedules for researchers tracking multiple substances
- Scheduling logic errors cause duplicate entries for single doses, creating confusion in daily tracking workflows
Single-market publisher, every app ships only to United States.
Based on 1 of 1 app with localized market data · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
1
Positive apps
0
Neutral / mixed
0
Negative apps
65/100
Avg sentiment score
Rivals
Who does Christopher Madrid compete with?
The rivals identified
Nemeses(1)
Both apps target users managing peptide protocols, with Peptide Tracker & Calculator offering a free, high-volume alternative to PeptideJournal's paid, privacy-focused model.
Contenders(10)
Regimen competes for the same peptide-tracking audience by offering a broader feature set, including Apple Health integration and progress photo tracking, which directly challenges the utility-focused scope of PeptideJournal.
Both apps target users managing peptide protocols with overlapping core functionality in dosage calculation and inventory tracking.
PeptideKit competes directly for the same user base by offering flexible scheduling and broader tracking features for individuals managing peptide and hormone therapy protocols.
Both apps target individuals managing peptide and medication protocols, competing directly on dosing calculation and scheduling utility for research and health tracking.
Both apps target researchers managing peptide protocols through dosage calculation and scheduling tools, creating direct competition for the same user base.
PepKit targets the same user base of peptide researchers by offering a free, feature-complete alternative to the paid PeptideJournal. It directly overlaps on core functionality like dose calculation and protocol scheduling.
Injectly competes for the same user base by offering a free, cloud-synced alternative for tracking injectable medications, directly challenging the paid, local-only model of PeptideJournal.
Both apps target researchers managing peptide protocols, sharing core functionality in inventory management and reconstitution calculations.
OptiPin targets the same peptide and hormone tracking audience with a free, feature-rich model that directly challenges PeptideJournal's paid, manual-entry approach.
Both apps target users managing complex peptide protocols with specialized calculators, creating direct competition for the same niche user base.
Same space(7)
This app targets the same research-oriented audience while expanding the scope to include GLP-1 and TRT medication tracking.
This app addresses the same protocol management needs but currently lacks the user base to challenge established tools.
This app competes for the same privacy-conscious user base while adding cross-platform health data integration.
This app serves as a specialized alternative for users who require a strict, manual vial ledger without automated coaching.
This app provides a similar protocol-building utility but suffers from significant user dissatisfaction regarding reliability.
This app focuses on the same inventory and dosing needs but emphasizes visual data representation for active levels.
This app offers a broader health-tracking experience by integrating nutrition and wellness metrics alongside peptide injection logs.
The Analyst's Read
The bottom line on Christopher Madrid
Bottom line
Christopher Madrid is a niche indie developer successfully targeting the specialized peptide research market with a privacy-first, utility-heavy tool. The app's technical specificity and local-storage model provide a clear alternative to mainstream health platforms for privacy-conscious power users.
Frequently asked questions
How many apps does Christopher Madrid publish?
What kind of apps does Christopher Madrid make?
What is Christopher Madrid's top app?
In how many countries are Christopher Madrid's apps available?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 0
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- no